Literature DB >> 16281426

Introduction to Bayesian methods I: measuring the strength of evidence.

Steven N Goodman1.   

Abstract

Bayesian inference is a formal method to combine evidence external to a study, represented by a prior probability curve, with the evidence generated by the study, represented by a likelihood function. Because Bayes theorem provides a proper way to measure and to combine study evidence, Bayesian methods can be viewed as a calculus of evidence, not just belief. In this introduction, we explore the properties and consequences of using the Bayesian measure of evidence, the Bayes factor (in its simplest form, the likelihood ratio). The Bayes factor compares the relative support given to two hypotheses by the data, in contrast to the P-value, which is calculated with reference only to the null hypothesis. This comparative property of the Bayes factor, combined with the need to explicitly predefine the alternative hypothesis, produces a different assessment of the strength of evidence against the null hypothesis than does the P-value, and it gives Bayesian procedures attractive frequency properties. However, the most important contribution of Bayesian methods is the way in which they affect both who participates in a scientific dialogue, and what is discussed. With the emphasis moved from "error rates" to evidence, content experts have an opportunity for their input to be meaningfully incorporated, making it easier for regulatory decisions to be made correctly.

Mesh:

Year:  2005        PMID: 16281426     DOI: 10.1191/1740774505cn098oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  48 in total

1.  Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models.

Authors:  M Pai; N Dendukuri; L Wang; R Joshi; S Kalantri; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2008-08       Impact factor: 2.373

2.  How many patients with severe sepsis are needed to confirm the efficacy of drotrecogin alfa activated? A Bayesian design.

Authors:  Andre C Kalil; Junfeng Sun
Journal:  Intensive Care Med       Date:  2008-05-27       Impact factor: 17.440

3.  Significance testing as perverse probabilistic reasoning.

Authors:  M Brandon Westover; Kenneth D Westover; Matt T Bianchi
Journal:  BMC Med       Date:  2011-02-28       Impact factor: 8.775

4.  The researcher and the consultant: from testing to probability statements.

Authors:  Ghassan B Hamra; Andreas Stang; Charles Poole
Journal:  Eur J Epidemiol       Date:  2015-06-25       Impact factor: 8.082

5.  For and Against Methodologies: Some Perspectives on Recent Causal and Statistical Inference Debates.

Authors:  Sander Greenland
Journal:  Eur J Epidemiol       Date:  2017-02-20       Impact factor: 8.082

6.  Thou Shalt Not Bear False Witness Against Null Hypothesis Significance Testing.

Authors:  Miguel A García-Pérez
Journal:  Educ Psychol Meas       Date:  2016-10-05       Impact factor: 2.821

7.  Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.

Authors:  Paul M Cinciripini; Charles E Green; Jason D Robinson; Maher Karam-Hage; Jeffrey M Engelmann; Jennifer A Minnix; David W Wetter; Francesco Versace
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

8.  Bayesian adaptive randomization designs for targeted agent development.

Authors:  J Jack Lee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

9.  Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Norman B Schmidt; Elizabeth M Lewis; Daniel J Paulus; Paula Lopez-Gamundi; Kathleen A Crapanzano; Jafar Bakhshaie
Journal:  Behav Res Ther       Date:  2018-10-26

10.  A nomogram for P values.

Authors:  Leonhard Held
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.